Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Mirikizumab for Children and Teens with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy The Netherlands +4
  • A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Germany +7
  • One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +8
  • A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark Germany Italy Poland Spain
  • A study testing how well mirikizumab works to achieve transmural healing in patients with Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Long-term safety study of tulisokibart in adults with Crohn’s disease or ulcerative colitis

    Recruiting

    3 1
    Investigated Drugs:
    Czechia France Hungary Poland
  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    Austria Belgium Bulgaria Croatia Czechia France +8
  • A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +9
  • A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +9